TCL Archive Cancer Organizations Continue Reform Lobbying: Target Issue Are Off-Label Drugs, Clinical Trials March 26, 1993
TCL Archive In This Issue: Congressional Testimony On NIH, NCI Appropriations, FDA Reform May 9, 1997
TCL Archive Cancer center directors to develop blueprint for progress that’s “honest,” M.D. Anderson’s John Mendelsohn says. November 23, 2005